Safety and efficacy of Interferon y in Friedreich ataxia, using clinical and paraclinical indicators of disease
- 1. Scientific Institute, IRCCS E. Medea, Italy
- 2. Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Athinoula A. Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, MA, USA
- 3. Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Fratagene Therapeutics, Rome, Italy
- 4. Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
Description
The data shared in the Zenodo repository include clinical and instrumental data from a randomized clinical trial open label phase II in Friedreich's Ataxia patients that underwent a 6 months treatment with interferone gamma and 6 months follow-up. Permission to use the data will be given only on direct request, correspondence to Prof. Andrea Martinuzzi ( andrea.martinuzzi@lanostrafamiglia.it ).
Files
Restricted
The record is publicly accessible, but files are restricted. Log in to check if you have access.
Request access
If you would like to request access to these files, please fill out the form below.
You need to satisfy these conditions in order for this request to be accepted:
The authors prefer to be contacted by anyone interested in having access to these data. Permission to use these data will be given on direct request. Correspondence to Prof. Andrea Martinuzzi: andrea.martinuzzi@lanostrafamiglia.it.
You are currently not logged in. Do you have an account? Log in here
Additional details
Related works
- Has part
- 10.5281/zenodo.3143302 (DOI)